12/08/2015

57th Annual General Meeting of the American Society of Hematology Presentation of clinical trial results from China on tamibarotene as a treatment for acute promyelocytic leukemia

01/30/2015

Notice of Completion of Investment inIriSys, LLC

01/20/2015

Notice of Investment in IriSys, LLC and Establishment of New U.S. Subsidiary

12/12/2014

Filing of IND for Connective Tissue Disease Associated Interstitial Lung Disease

09/29/2014

Notice of Exercise Price of Stock Option etc

09/12/2014

Notice of Granting Stock Option to Board of Directors

09/04/2014

Tokyo Administrative Office Relocation

09/01/2014

Re-assignment of Industry Category

07/01/2014

F351 Phase II Clinical Trial Approval

05/09/2014

Patent Allowance for Etuary and F351 in the U.S.

03/19/2014

Notice for completion of the registration of incorporation of a subsidiary

02/27/2014

Notice of Changing of Accounting Auditor

02/27/2014

Announcement of the 13th Annual General Shareholder Meeting

02/27/2014

Notice for the drug price and sales commencement for Etuary

02/03/2014

Notice for Exercise of the 37th Round of Stock Options in January, 2014